Navigation Links
Revolutionary Net To Control Malaria

More than 350 million new cases of malaria are reported each year. However, a revolutionary mosquito net being developed by textile experts from Leeds, //with funding from the Bill & Melinda Gates Foundation, has ushered in more hope for sustainable protection from the disease.

Design lecturer Dr Stephen Russell and medical entomologist Dr Bruce Alexander from Xeroshield at the Roslin Biocentre will develop a precisely engineered material that uses its structure to kill the mosquito. By relying on its structure, the net will avoid the problems of chemically treated nets, which are the main method of controlling malaria.

Existing chemically treated cotton or polyester nets need re-treating or replacing within 20-25 washes. The move away from insecticides has the added benefit of preventing mosquitoes from becoming resistant to these chemicals.

Dr Russell said: "For years, we've only seen small improvements in the design of mosquito nets and this research provides us a great opportunity to develop new insecticidal materials in a fundamentally different way. "We are taking an unconventional approach to the design and construction of the nets whilst maintaining their inherent breath ability, strength and durability."

Dr Alexander said: "Not only is this potentially a safer and cheaper method of protecting people, it will also avoid the problem of chemical resistance. We're already seeing bedbugs in the mattresses covered by nets becoming resistant to pyrethroids. We need to break the cycle of playing catch-up as insects develop resistance to insecticides."
"The new nets would be a more sustainable way of protecting people from mosquitoes and – we hope – could go some way to preventing some of the one million plus deaths from malaria seen every year."

The £360,000 funding from the Bill & Melinda Gates Foundation for the three year project was raised with support of the North America Foundation for the U niversity of Leeds.

"Entrenched global health problems, such as malaria, require innovative solutions," said Dr Regina Rabinovich, director of the Gates Foundation's Infectious Diseases program. "If successful, this research could produce an important new tool to fight malaria in the world's poorest countries."

SOURCE:EUREKALERT ##
'"/>




Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. Revolutionary Pill Cuts Risk of Breast Cancer
3. A Revolutionary New Treatment For Cancer Available In Australia
4. New Revolutionary Drug Could Stop the Spread of HIV
5. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. FDA Approves Birth Control Skin Patch
10. Control of inflammation
11. New Birth Control Pills increase the stroke risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the United ... persecution, Center for Medicine after the Holocaust (CMATH) announced that it will ... and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany and ...
(Date:4/24/2017)... ... , ... Today, Bright Pink , a national non-profit organization focusing on the prevention and ... , Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. ... as Chairman of the Board and launched a national search to find a visionary ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
(Date:4/24/2017)... ... 2017 , ... The world-class designers of Happy Gadget Alert ... lifesaving device for the everyday use of parents worldwide. It is a lightweight, ... a child’s vital signs, and detect unusual symptoms or physical patterns. This innovative ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: